Health Care M&A Deals, Week Ending September 21, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Amicus Therapeutics, Inc. Celenex $100 million Corbus Pharmaceuticals License to 600 compounds N/A Thompson Street Capital Partners LifeSpan Biosciences Inc. N/A eHealth Acquirer Target Price Med Tech Solutions Compex, Inc. N/A Waystar Connance N/A Home... Read More »
Health Care M&A Deals, Week Ending September 14, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Fulcrum Equity Partners Life of Purpose Treatment Centers N/A 360 Behavioral Health Passport to Adaptive Living N/A Biotechnology Acquirer Target Price Allergan plc Bonti, Inc. $195 million Boehringer Ingelheim... Read More »
Health Care M&A Deals, Week Ending September 7, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price United Therapeutics Corp. Collaboration on pulmonary hypertension products $45 million Kwang Dong Pharmaceutical Co., Ltd. License to ATB-346 $9.8 million Biohaven Pharmaceutical Holding Company Ltd. License to AZD3241 N/A Shire plc Sanaplasma AG N/A... Read More »
August 2018 Sets New Record for Health Care Deals
Did any of you deal makers take a vacation last month? I know for a fact that many of you did, but the pace of deal announcements didn’t slow for a moment in August 2018. Deal volume reached 144 and still counting, a new record for the month. The total got a boost from a suddenly hot Long-Term Care sector, which logged 46 transactions. That’s a 70% boost compared with the 27 deals reported in both July 2018 and August 2017. Looking back through our database, August has been fairly quiet for the past 20 years, as far as deal volume is concerned. Way back in August 1997, 113 transactions were announced, and that was before we began tracking the technology sectors—Biotechnology, eHealth,... Read More »
